Recent Company News

• 08:46 AM ET Aug 25, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:37 PM ET Aug 25, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:52 PM ET Aug 22, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 01:31 PM ET Aug 22, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 24-Aug

• 11:09 PM ET Aug 18, 2025
  

  Singapore approves Beyfortus (nirsevimab) for prevention of RSV in newborns and infants (€85.58, 0.00)

• 03:01 PM ET Aug 14, 2025
  

  UK's MHRA approves teplizumab for treatment of type 1 diabetes (earlier)